만전제약(8225.HK)는 HKS에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 0.08홍콩달러 (+0.00%), 시가총액 7,963만홍콩달러, 52주 범위 0.08홍콩달러 ~ 0.18홍콩달러.
China Health Group Inc., together with its subsidiaries, researches and develops bio, natural, and synthetic drugs in the People's Republic of China. It engages in the pharmacodynamics and clinical research of drugs; provision of post market and contracted pharmaceutical development services; and technological transfer and services for the research and development of drugs. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in February 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, China.
만전제약의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
만전제약의 현재 주가는 0.08홍콩달러 (+0.00%)입니다. XTS에서 시세와 차트를 확인할 수 있습니다.
만전제약의 시가총액은 약 7,963만홍콩달러입니다.
China Health Group Inc., together with its subsidiaries, researches and develops bio, natural, and synthetic drugs in the People's Republic of China.